Tarsus Pharmaceuticals, Inc.
$68.07
-2.92 (-4.11%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -13.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -25.0%
Own TARS?
See how TARS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.